JULIA HUTT: Open Payments
NPI 1295985273 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 12 payments from 7 companies in 2025. Trend: 2023 $614 · 2024 $362 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 3 | $55 |
| ABBVIE INC. | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Lilly USA, LLC | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: TZIELD, UBRELVY, KISUNLA, BREZTRI, CAPLYTA, FREESTYLE LIBRE 3, FARXIGA, XIFAXAN.
Industry payments across AL — which companies pay providers there.
